An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids
Clinical trial NCT02811159 · TERMINATED
Trial details
- NCT number
- NCT02811159
- Sponsor
- Repros Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-26
- Primary completion
- 2017-05-04
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.